Medicare Enrolled
Dr. Pui-Sum Wong, M.D.
Internal Medicine · Texarkana, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wong
Dr. Pui-Sum Wong is an internal medicine specialist in Texarkana, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wong performed 49,632 Medicare services across 9,908 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wong received a total of $4,247 from 42 pharmaceutical and/or device companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wong is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in TX
$4,247 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,632
Medicare services
Top 1% in TX for internal medicine
9,908
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,482 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 19,530 | $8 | $15 |
| Denosumab injection (Prolia/Xgeva) | 11,940 | $18 | $25 |
| Blood draw (venipuncture) | 2,440 | $8 | $20 |
| Office visit, established patient (30-39 min) | 2,145 | $85 | $245 |
| Comprehensive metabolic blood panel | 1,933 | $10 | $105 |
| Complete blood count (CBC) with differential | 1,528 | $8 | $48 |
| Lipid panel (cholesterol and triglycerides) | 1,280 | $13 | $90 |
| Thyroid stimulating hormone (TSH) test | 1,108 | $16 | $86 |
| Hemoglobin A1c test (diabetes monitoring) | 1,021 | $9 | $61 |
| Office visit, established patient (20-29 min) | 761 | $56 | $175 |
| Urine microalbumin test (kidney screening) | 528 | $6 | $60 |
| Urinalysis with microscopic exam | 501 | $3 | $28 |
| Annual wellness visit, follow-up | 399 | $124 | $220 |
| Drug injection, under skin or into muscle | 375 | $11 | $42 |
| Flu vaccine administration | 337 | $30 | $35 |
| Free thyroxine (T4) test | 329 | $9 | $52 |
| Flu vaccine, high-dose | 329 | $72 | $75 |
| Basic metabolic blood panel | 323 | $8 | $88 |
| Parathyroid hormone level test | 230 | $40 | $163 |
| Vitamin D level test | 208 | $29 | $248 |
| Electrocardiogram (EKG), 12-lead | 162 | $9 | $76 |
| Prothrombin time test (blood clotting) | 138 | $4 | $26 |
| Creatine kinase (cardiac enzyme) level, total | 136 | $6 | $29 |
| Vitamin B-12 level test | 126 | $15 | $70 |
| EKG interpretation and report | 116 | $6 | $38 |
| Ferritin level test (iron stores) | 86 | $13 | $52 |
| Iron level test | 81 | $6 | $39 |
| Red blood cell concentration measurement | 75 | $2 | $21 |
| Blood count, hemoglobin | 75 | $2 | $22 |
| Transferrin (iron binding protein) level | 71 | $12 | $50 |
| Administration of vaccine | 69 | $13 | $48 |
| Urine culture, bacterial identification | 68 | $8 | $42 |
| Chest X-ray, 2 views | 65 | $15 | $44 |
| Ceftriaxone antibiotic injection | 60 | $0 | $14 |
| Office visit, established patient, complex (40-54 min) | 59 | $120 | $345 |
| Natriuretic peptide (heart and blood vessel protein) level | 52 | $38 | $171 |
| Uric acid level test | 52 | $4 | $24 |
| Thyroid hormone, t3 measurement, free | 51 | $17 | $120 |
| Bacterial culture, aerobic | 46 | $8 | $40 |
| Antibiotic sensitivity test | 45 | $8 | $58 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 45 | $30 | $110 |
| Prostate cancer screening; prostate specific antigen test (psa) | 43 | $19 | $79 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 42 | $275 | $325 |
| C-reactive protein test (inflammation marker) | 40 | $5 | $23 |
| PSA test (prostate cancer screening) | 38 | $18 | $79 |
| Sed rate test (inflammation marker) | 37 | $3 | $26 |
| Pneumonia vaccine administration | 36 | $30 | $45 |
| Injection, methylprednisolone acetate, 80 mg | 36 | $8 | $26 |
| Injection, ketorolac tromethamine, per 15 mg | 34 | $0 | $17 |
| Knee X-ray, 3 views | 33 | $18 | $66 |
| Magnesium level test | 33 | $7 | $37 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 32 | $38 | $155 |
| Joint injection, major joint | 26 | $43 | $205 |
| Creatinine test (kidney function) | 25 | $5 | $22 |
| Total protein level, urine | 24 | $4 | $24 |
| X-ray of lower and sacral spine, 2-3 views | 19 | $19 | $54 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $20 | $55 |
| New patient office visit (45-59 min) | 19 | $105 | $315 |
| Initial hospital admission, moderate complexity | 18 | $101 | $255 |
| Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 16 | $45 | $58 |
| Shoulder X-ray, 2+ views | 15 | $18 | $61 |
| Administration of vaccine, each additional vaccine | 15 | $10 | $25 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 15 | $161 | $190 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $161 | $325 |
| Folic acid level test | 14 | $14 | $79 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 14 | $35 | $168 |
| Transitional care management services for problem of at least moderate complexity | 14 | $158 | $280 |
| Blood creatinine level | 13 | $5 | $28 |
| Transitional care management services for problem of high complexity | 13 | $215 | $395 |
| Complete blood count (CBC), automated | 11 | $6 | $38 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,247
Total received (2018-2024)
Avg $607/year across 7 years
Top 19% in TX for internal medicine
42
Companies
298
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,222 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$691
2023
$886
2022
$582
2021
$527
2020
$283
2019
$537
2018
$741
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$644
PFIZER INC.
$361
Novartis Pharmaceuticals Corporation
$329
Janssen Pharmaceuticals, Inc
$317
Lilly USA, LLC
$292
AbbVie Inc.
$284
Amarin Pharma Inc.
$233
ABBVIE INC.
$207
AstraZeneca Pharmaceuticals LP
$138
E.R. Squibb & Sons, L.L.C.
$123
SANOFI-AVENTIS U.S. LLC
$122
Abbott Laboratories
$112
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$90
Dexcom, Inc.
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
Novo Nordisk Inc
$82
Allergan Inc.
$76
GlaxoSmithKline, LLC.
$76
Eisai Inc.
$61
Alnylam Pharmaceuticals Inc.
$41
Allergan, Inc.
$33
Sanofi Pasteur Inc.
$32
Astellas Pharma US Inc
$31
Arbor Pharmaceuticals, Inc.
$28
Optinose US, Inc.
$27
Merck Sharp & Dohme Corporation
$27
Horizon Therapeutics plc
$26
Currax Pharmaceuticals LLC
$25
Braintree Laboratories, Inc.
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Phathom Pharmaceuticals, Inc.
$23
Janssen Biotech, Inc.
$23
Boston Scientific Corporation
$21
Almatica Pharma LLC
$21
Evoke Pharma, Inc.
$20
EVOKE PHARMA, INC.
$18
Nestle HealthCare Nutrition Inc.
$17
Merck Sharp & Dohme LLC
$14
Esperion Therapeutics, Inc.
$13
Nevro Corp.
$13
Kowa Pharmaceuticals America, Inc.
$13
ARBOR PHARMACEUTICALS, INC.
$13
Top 3 companies account for 31.4% of total payments
Associated products mentioned in payments ›
Aimovig · Amitiza · BELSOMRA · CAMZYOS · CHANTIX · CREON · DUEXIS · Dayvigo · Dexcom G6 Transmitter · Dexilant · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GIMOTI · GRALISE · INVOKANA · JARDIANCE · LEQVIO · LINZESS · LYRICA · Leqembi · Livalo · MOTOFEN · NEXLETOL · ONPATTRO · Omnia · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR 20 · Prolia · QULIPTA · Repatha · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STIOLTO RESPIMAT · SUFLAVE · Saxenda · TOUJEO · TRULICITY · UBRELVY · VIAGRA · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · Xhance · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
40
Per 100K population
43.3
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Wong is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 19% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Wong experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Wong performed 19,530 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wong receive payments from pharmaceutical companies?
Yes. Dr. Wong received a total of $4,247 from 42 companies across 298 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wong's costs compare to other internal medicine physicians in Texarkana?
Dr. Wong's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Texarkana
Browse internal medicine physicians in Texarkana ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology